TABLE 4

Comparison of Other Collected Data

OutcomeControl Group (n = 143)SLI Group (n = 148)Unadjusted Odds Ratio (95% CI)P
RDS 134 (94)133 (90)0.60 (0.25–1.41).23
Pneumothorax 2 (1)9 (6)4.57 (0.97–21.50).06
Interstitial emphysema 2 (1)7 (5)3.50 (0.72–17.10).09
Pharmacologic treatment of PDA 70 (49)88 (59)1.53 (0.96–2.43).07
Surgical closure of PDA 8 (6)5 (3)0.59 (0.19–1.85).36
IVH 28 (20)37 (25)1.37 (0.79–2.39).27
 Grade ≥3 8 (6)12 (8)1.49 (0.59–3.76).39
PVL 5 (4)1 (1)0.19 (0.02–1.63).08
NEC 4 (3)7 (5)1.73 (0.49–6.03).38
ROPa58 (41)60 (41)0.99 (0.63–1.60).99
 Grade ≥3 12 (8)14 (9)1.14 (0.51–2.56).75
Sepsis 44 (31)54 (36)1.29 (0.79–2.11).30
  • Data are presented as n (%). IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitis; PDA, patent ductus arteriosus; PVL, periventricular leukomalacia; ROP, retinopathy of prematurity.

  • a Proportions are estimates of cumulative incidence of events in the presence of competing risks.